Jawhar Rawwas

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

Giselle L. Saulnier Sholler, William S. Ferguson, Genevieve Bergendahl et al. · Scientific Reports · 2018 · 107 citations · Full text

Medicine, Oncology, Pharmacology +10

PET hydroxyephedrine imaging of neuroblastoma.

Barry L. Shulkin, Donald M. Wieland, Marie E. Baro et al. · PubMed · 1996 · 77 citations

Medicine, Nuclear Medicine, Oncology +12

A subset analysis of a phase <scp>II</scp> trial evaluating the use of <scp>DFMO</scp> as maintenance therapy for high‐risk neuroblastoma

Elizabeth C. Lewis, Jacqueline M. Kraveka, William S. Ferguson et al. · International Journal of Cancer · 2020 · 64 citations · Full text

Medicine, Oncology, Immunotherapy +14

Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma

Anu Gupta, Bryan Williams, Samir Hanash et al. · Cancer Research · 2006 · 51 citations · Full text

Medicine, Molecular Biology, Oncology +14

FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones

Ioannis G. Koutlas, Damon R. Olson, Jawhar Rawwas · Head and Neck Pathology · 2020 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +8